SXI Bio+Medtech
4.701,72
PKT
-9,11
PKT
-0,19
%
Werbung
Analysen zu SXI Bio+Medtech-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 26.11.12 | Lonza hold | Vontobel Research | |
| 26.11.12 | Straumann neutral | Sarasin Research | |
| 23.11.12 | Sonova kaufen | Fuchsbriefe | |
| 22.11.12 | Basilea Pharmaceutica hold | Vontobel Research | |
| 14.11.12 | Sonova neutral | UBS AG | |
| 14.11.12 | Sonova overweight | J.P. Morgan Cazenove | |
| 14.11.12 | Sonova underperform | Exane-BNP Paribas SA | |
| 14.11.12 | Sonova buy | Vontobel Research | |
| 13.11.12 | Sonova buy | Vontobel Research | |
| 13.11.12 | Sonova neutral | Sarasin Research | |
| 12.11.12 | Sonova underperform | Exane-BNP Paribas SA | |
| 07.11.12 | Sonova equal-weight | Morgan Stanley | |
| 01.11.12 | Straumann underperform | Exane-BNP Paribas SA | |
| 01.11.12 | Lonza hold | Vontobel Research | |
| 31.10.12 | Straumann neutral | Nomura | |
| 31.10.12 | Straumann buy | Deutsche Bank AG | |
| 31.10.12 | Straumann hold | Vontobel Research | |
| 31.10.12 | Lonza hold | Vontobel Research | |
| 30.10.12 | Straumann underperform | Cheuvreux SA | |
| 30.10.12 | Straumann neutral | Sarasin Research | |
| 30.10.12 | Straumann hold | Vontobel Research | |
| 29.10.12 | Sonova buy | Vontobel Research | |
| 25.10.12 | Straumann underperform | Exane-BNP Paribas SA | |
| 24.10.12 | Sonova buy | Vontobel Research | |
| 22.10.12 | Sonova neutral | Sarasin Research | |
| 18.10.12 | BB Biotech halten | Independent Research GmbH | |
| 18.10.12 | Straumann hold | Vontobel Research | |
| 10.10.12 | Sonova underperform | Exane-BNP Paribas SA | |
| 05.10.12 | Lonza hold | Vontobel Research | |
| 05.10.12 | Sonova neutral | Sarasin Research | |
| 05.10.12 | Straumann hold | Vontobel Research | |
| 05.10.12 | Sonova buy | Vontobel Research | |
| 02.10.12 | Tecan (N) neutral | Sarasin Research | |
| 27.09.12 | Sonova neutral | Sarasin Research | |
| 27.09.12 | Sonova underperform | Exane-BNP Paribas SA | |
| 14.09.12 | Lonza neutral | J.P. Morgan Cazenove | |
| 11.09.12 | Newron PharmaceuticalsAz. buy | Vontobel Research | |
| 10.09.12 | Newron PharmaceuticalsAz. buy | Vontobel Research | |
| 27.08.12 | Straumann reduce | Commerzbank Corp. & Markets | |
| 22.08.12 | Straumann neutral | UBS AG |